Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Vanguard Total Bond Market
BND
$158B
| $579K | ﹤0.01% |
7,693
-12,340
| -62% | -$939K |
|
627
SPDR Gold Trust
GLD
$132B
| $578K | ﹤0.01% |
3,434
-2,291
| -40% | -$400K |
|
628
Sempra
SRE
$56.6B
| $566K | ﹤0.01% |
7,526
+4,334
| +136% | +$348K |
|
629
Mondelez International
MDLZ
$79.2B
| $560K | ﹤0.01% |
9,020
-1,272
| -12% | -$80.4K |
|
630
Target
TGT
$67.3B
| $554K | ﹤0.01% |
3,924
+493
| +14% | +$94.5K |
|
631
Wabtec
WAB
$50.5B
| $548K | ﹤0.01% |
6,679
-86
| -1% | -$7.67K |
|
632
Eagle Bancorp
EGBN
$865M
| $545K | ﹤0.01% |
11,493
| – | – |
|
633
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
| $544K | ﹤0.01% |
5,635
+2,129
| +61% | +$227K |
|
634
Illinois Tool Works
ITW
$84.9B
| $542K | ﹤0.01% |
+2,973
| New | +$595K |
|
|
ONC
635
BeOne Medicines Ltd
ONC
$33.5B
| $542K | ﹤0.01% |
3,349
+2
| +0.1% | +$312 |
|
636
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
| $538K | ﹤0.01% |
10,553
+53
| +0.5% | +$2.76K |
|
637
Air Products & Chemicals
APD
$65.6B
| $534K | ﹤0.01% |
2,219
+1,106
| +99% | +$269K |
|
638
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
| $534K | ﹤0.01% |
10,689
-781
| -7% | -$39.1K |
|
639
SEI Investments
SEIC
$12.6B
| $533K | ﹤0.01% |
9,858
+225
| +2% | +$12.7K |
|
640
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $523K | ﹤0.01% |
11,550
-11,565
| -50% | -$571K |
|
641
Blackstone
BX
$110B
| $521K | ﹤0.01% |
5,706
+1,140
| +25% | +$123K |
|
642
iShares Russell 2000 ETF
IWM
$83B
| $509K | ﹤0.01% |
3,006
+47
| +2% | +$8.66K |
|
643
NIO
NIO
$11.9B
| $506K | ﹤0.01% |
23,284
+7,536
| +48% | +$138K |
|
644
Heron Therapeutics
HRTX
$96.8M
| $505K | ﹤0.01% |
181,181
+300
| +0.2% | +$1.21K |
|
645
Newmont
NEM
$103B
| $501K | ﹤0.01% |
8,391
+5,605
| +201% | +$397K |
|
646
Brookfield
BN
$109B
| $495K | ﹤0.01% |
20,674
-271
| -1% | -$7.24K |
|
647
Emerson Electric
EMR
$89B
| $494K | ﹤0.01% |
6,213
+653
| +12% | +$57.6K |
|
648
Corning
GLW
$137B
| $491K | ﹤0.01% |
15,587
+7,405
| +91% | +$255K |
|
649
Agilent Technologies
A
$39.3B
| $488K | ﹤0.01% |
+4,111
| New | +$505K |
|
650
Phillips 66
PSX
$82.5B
| $481K | ﹤0.01% |
5,861
-2,030
| -26% | -$188K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.